David T Curiel

St. Louis, MO, United States of America

David T Curiel

USPTO Granted Patents = 40 

 

Average Co-Inventor Count = 2.5

ph-index = 16

Forward Citations = 965(Granted Patents)


Location History:

  • Chapel Hill, NC (US) (1996 - 2001)
  • Birmingham, AL (US) (1999 - 2007)
  • Saint Louis, MO (US) (2016)
  • St. Louis, MO (US) (2019 - 2023)

Company Filing History:


Years Active: 1996-2023

Loading Chart...
Loading Chart...
40 patents (USPTO):Explore Patents

Title: David T Curiel: Innovator in Cancer Research and Therapeutics

Introduction

David T Curiel is a prominent inventor based in Birmingham, Alabama, known for his groundbreaking contributions to cancer research through innovative therapies. With an impressive portfolio consisting of 33 patents, Curiel has made significant strides in the field of oncolytic virotherapy, focusing on the development of novel methods to treat cancer.

Latest Patents

Among his latest inventions is a patent for an oncolytic adenoviral vector and methods of use. This invention involves a conditionally-replicating serotype 5 adenovirus or adenoviral vector that expresses a mutant E1A protein controlled by a promoter responsive to hypoxia and inflammation. The vector also comprises serotype 3 fiber and hexon proteins, presenting a method for inducing cytotoxicity in tumor cells through an innovative composition. Another notable patent is for tropic cell-based virotherapy, where the methods provided include killing tumor cells by using a tropic cell that carries a modified oncolytic virus with tumor selective elements. These advancements illustrate Curiel’s commitment to addressing complex challenges in cancer treatment.

Career Highlights

Curiel's career is marked by his association with the UAB Research Foundation, where he has contributed to several pioneering projects related to therapeutic developments. His work has not only advanced the understanding of cancer therapies but has also opened new avenues for research and development in oncology.

Collaborations

Throughout his career, David T Curiel has collaborated with esteemed professionals in the field, including Donald J Buchsbaum and Murray A Stackhouse. These interactions have fostered a collaborative environment that enhances innovation and amplifies the impact of their research endeavors.

Conclusion

David T Curiel exemplifies the role of an inventor committed to making a difference in the medical field, particularly in cancer treatment. With a strong portfolio of patents and valuable collaborations, he continues to push the boundaries of science and research, paving the way for new therapies that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…